We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$525M
AUM Growth
+$86.1M
Cap. Flow
+$50.1M
Cap. Flow %
9.53%
Top 10 Hldgs %
56.68%
Holding
32
New
4
Increased
11
Reduced
14
Closed
3

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$29.1M
2
GILD icon
Gilead Sciences
GILD
+$21.8M
3
PFE icon
Pfizer
PFE
+$21.8M
4
MRK icon
Merck
MRK
+$14.8M
5
CNC icon
Centene
CNC
+$12.3M

Top Sells

Rank Stock Value
1
A icon
Agilent Technologies
A
+$17.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$11.1M
3
MDT icon
Medtronic
MDT
+$9.09M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$8.64M
5
RVTY icon
Revvity
RVTY
+$7.82M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$165B
$48.8M 9.29%
838,140
+361,046
+76% +$21.8M
MRK icon
2
Merck
MRK
$307B
$47.3M 9%
605,965
+193,709
+47% +$14.8M
INCY icon
3
Incyte
INCY
$23.1B
$30.6M 5.82%
351,629
+66,725
+23% +$5.77M
BDX icon
4
Becton Dickinson
BDX
$42.6B
$30.5M 5.8%
+124,891
New +$29.1M
MDT icon
5
Medtronic
MDT
$107B
$27.8M 5.29%
237,523
-82,598
-26% -$9.09M
BSX icon
6
Boston Scientific
BSX
$65.1B
$24.8M 4.72%
690,282
+135,280
+24% +$4.88M
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$23.1M 4.4%
147,827
-67,241
-31% -$8.64M
BMY icon
8
Bristol-Myers Squibb
BMY
$123B
$22.4M 4.27%
361,343
-179,851
-33% -$11.1M
PFE icon
9
Pfizer
PFE
$141B
$21.8M 4.16%
+593,250
New +$21.8M
RVTY icon
10
Revvity
RVTY
$11.9B
$20.7M 3.93%
143,931
-58,776
-29% -$7.82M
IONS icon
11
Ionis Pharmaceuticals
IONS
$8.75B
$18.1M 3.45%
320,992
+84,650
+36% +$4.22M
BRKR icon
12
Bruker
BRKR
$8.55B
$17.7M 3.37%
327,477
-59,484
-15% -$2.85M
ABT icon
13
Abbott
ABT
$177B
$16.7M 3.18%
152,640
-17,579
-10% -$1.91M
CVS icon
14
CVS Health
CVS
$137B
$16.1M 3.07%
235,818
-15,963
-6% -$1.04M
BIIB icon
15
Biogen
BIIB
$29.5B
$16.1M 3.06%
65,585
-1,758
-3% -$454K
CAH icon
16
Cardinal Health
CAH
$52.9B
$15.6M 2.96%
290,850
+5,569
+2% +$289K
ELV icon
17
Elevance Health
ELV
$82.9B
$15.2M 2.89%
47,360
-20,442
-30% -$6.27M
LH icon
18
Labcorp
LH
$23.1B
$14.7M 2.79%
83,882
+13,736
+20% +$2.37M
NUVA
19
DELISTED
NuVasive, Inc.
NUVA
$14.4M 2.74%
255,360
-34,076
-12% -$1.68M
LIVN icon
20
LivaNova
LIVN
$4.35B
$13.3M 2.54%
201,230
+57,869
+40% +$3.22M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.08B
$12.5M 2.38%
21,417
-4,035
-16% -$2.3M
CNC icon
22
Centene
CNC
$32.5B
$11.6M 2.22%
+194,012
New +$12.3M
ELAN icon
23
Elanco Animal Health
ELAN
$12.6B
$11.3M 2.15%
368,291
+168,180
+84% +$5.13M
HCA icon
24
HCA Healthcare
HCA
$82.2B
$10.6M 2.01%
64,210
-1,746
-3% -$255K
PRGO icon
25
Perrigo
PRGO
$1.47B
$7.51M 1.43%
167,922
-48,858
-23% -$2.26M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2020 Portfolio in Review

As of Q4 2020, Sector Gamma AS held 32 positions worth $525M, up 20% from $439M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sector Gamma AS deployed $50.1M of net new capital in Q4 2020, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Becton Dickinson: 124,891 shares worth $30.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $11.1M trimmed.

  • Sector Gamma AS's largest Q4 2020 buy was Becton Dickinson: 124,891 shares worth $30.5M.
  • Sector Gamma AS added most to Gilead Sciences in Q4 2020, an estimated $21.8M increase.
  • Sector Gamma AS's biggest Q4 2020 reduction was Bristol-Myers Squibb, cutting an estimated $11.1M.
  • Sector Gamma AS fully exited Agilent Technologies in Q4 2020, selling an estimated $17.1M.
  • Sector Gamma AS's ten largest holdings make up 57% of its $525M portfolio in Q4 2020.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q4 2020.
  • Sector Gamma AS's portfolio value rose 20% quarter-over-quarter to $525M.

Based on Sector Gamma AS's 13F filing for Q4 2020, filed 10 Feb 2021.